{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T18:07:48Z","timestamp":1758823668702},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1097\/med.0b013e328352f013","type":"journal-article","created":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T16:03:57Z","timestamp":1377878637000},"page":"159-167","source":"Crossref","is-referenced-by-count":8,"title":["Genetics of adrenocortical disease"],"prefix":"10.1097","volume":"19","author":[{"given":"Adi","family":"Bar-Lev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin P.","family":"Annes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-4-20211004","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000315959","article-title":"Impact of molecular genetics on congenital adrenal hyperplasia management.","volume":"4","author":"Balsamo","year":"2010","journal-title":"Sex Dev"},{"key":"R3-4-20211004","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/jcb.22979","article-title":"Nonsense suppressor therapies rescue peroxisome lipid metabolism and assembly in cells from patients with specific PEX gene mutations.","volume":"112","author":"Dranchak","year":"2011","journal-title":"J Cell Biochem"},{"key":"R4-4-20211004","doi-asserted-by":"crossref","first-page":"E728","DOI":"10.1210\/jc.2010-2420","article-title":"Integrated genomic analysis of nodular tissue in macronodular adrenocortical hyperplasia: progression of tumorigenesis in a disorder associated with multiple benign lesions.","volume":"96","author":"Almeida","year":"2011","journal-title":"J Endocrinol Metab"},{"key":"R5-4-20211004","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1471-2350-12-111","article-title":"Genome-wide copy number variation (CNV) in patients with autoimmune Addisons disease.","volume":"12","author":"Bronstad","year":"2011","journal-title":"BMC Med Genet"},{"key":"R6-4-20211004","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ymgme.2011.05.016","article-title":"X-linked adrenoleukodystrophy: ABCD1 de novo mutations and mosaicism.","volume":"104","author":"Wang","year":"2011","journal-title":"Mol Genet Metab"},{"key":"R7-4-20211004","doi-asserted-by":"crossref","first-page":"E1798","DOI":"10.1210\/jc.2011-1277","article-title":"A novel entity of clinically isolated adrenal insufficiency caused by a partially inactivating mutation of the gene encoding for P450 side chain cleavage enzyme (CYP11A1).","volume":"96","author":"Parajes","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R8-4-20211004","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1687-9856-2011-5","article-title":"Early onset obesity and adrenal insufficiency associated with a homozygous POMC mutation.","volume":"2011","author":"Mendiratta","year":"2011","journal-title":"Int J Pediatr Endocrinol"},{"key":"R9-4-20211004","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1530\/EJE-11-0119","article-title":"Relationship of CYP21A2 genotype and serum 17-hydroxyprogesterone and cortisol levels in a large cohort of Italian children with premature pubarche.","volume":"165","author":"Ghizzoni","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"R10-4-20211004","doi-asserted-by":"crossref","first-page":"E161","DOI":"10.1210\/jc.2010-0319","article-title":"Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.","volume":"96","author":"Finkielstain","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R11-4-20211004","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1530\/EJE-10-0764","article-title":"Impaired hepatic drug and steroid metabolism in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency.","volume":"163","author":"Tomalik-Scharte","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"R12-4-20211004","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejmg.2010.10.005","article-title":"Chimeric CYP21A1PCYP21A2 genes identified in Czech patients with congenital adrenal hyperplasia.","volume":"54","author":"Vrzalova","year":"2011","journal-title":"Eur J Med Genet"},{"key":"R13-4-20211004","first-page":"498","article-title":"Correlation between genotype and hormonal levels in heterozygous mutation carriers and noncarriers of 21-hydroxylase deficiency.","volume":"34","author":"Napolitano","year":"2011","journal-title":"J Endocrinol Invest"},{"key":"R14-4-20211004","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1210\/jc.2010-1828","article-title":"Partial defect in the cholesterol side-chain cleavage enzyme P450scc (CPY11A1) resembling nonclassic congenital lipoid adrenal hyperplasia.","volume":"96","author":"Sahakitrungruang","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R15-4-20211004","doi-asserted-by":"crossref","first-page":"e20178","DOI":"10.1371\/journal.pone.0020178","article-title":"Characterization of novel StAR (steroidogenic acute regulatory protein) mutations causing nonclassic lipoid adrenal hyperplasia.","volume":"6","author":"Fluck","year":"2011","journal-title":"PLoS One"},{"key":"R16-4-20211004","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1530\/EJE-10-1085","article-title":"Gene expression profiles in aldosterone-producing adenomas and adjacent adrenal glands.","volume":"164","author":"Wang","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"R17-4-20211004","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mce.2011.09.010","article-title":"Towards an understanding of the role of p53 in adrenocortical carcinogenesis.","volume":"351","author":"Wasserman","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"R18-4-20211004","doi-asserted-by":"crossref","first-page":"E1650","DOI":"10.1210\/jc.2011-0288","article-title":"on behalf of the Dutch POPS-19 Collaborative Study GroupAbdominal fat accumulation in adults born preterm exposed antenatally to maternal glucocorticoid treatment is dependent on glucocorticoid receptor gene variation.","volume":"96","author":"Finken","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R19-4-20211004","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4161\/epi.6.5.15236","article-title":"Birthweight is associated with DNA promoter methylation of the glucocorticoid receptor in human placenta.","volume":"6","author":"Filiberto","year":"2011","journal-title":"Epigenetics"},{"key":"R20-4-20211004","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1681\/ASN.2011030245","article-title":"Mineralocorticoid receptor mutations and a severe recessive Pseudohypoaldosteronism type 1.","volume":"22","author":"Hubert","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R21-4-20211004","doi-asserted-by":"crossref","first-page":"E467","DOI":"10.1152\/ajpendo.00066.2011","article-title":"A homozygous missense mutation in SCNN1A is responsible for a transient neonatal form of pseudohypoaldosteronism type 1.","volume":"301","author":"Dirlewanger","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R22-4-20211004","doi-asserted-by":"crossref","first-page":"E121","DOI":"10.1210\/jc.2011-0407","article-title":"Deficit in Anterior pituitary function and Variable Immune Deficiency (DAVID) in children presenting with adrenocorticotropin deficiency and severe infections.","volume":"97","author":"Quentien","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R23-4-20211004","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00431-011-1393-x","article-title":"A novel mutation of LHX3 is associated with combined pituitary hormone deficiency including ACTH deficiency, sensorineural hearing loss, and short neck-a case report and review of the literature.","volume":"170","author":"Bonfig","year":"2011","journal-title":"Eur J Pediatr"},{"key":"R24-4-20211004","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ecl.2011.01.012","article-title":"Glucocorticoid-remediable aldosteronism.","volume":"40","author":"Halperin","year":"2011","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R25-4-20211004","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00431-010-1314-4","article-title":"Two siblings with triple A syndrome and novel mutation presenting as hereditary polyneuropathy.","volume":"170","author":"Dumic","year":"2011","journal-title":"Eur J Pediatr"},{"key":"R26-4-20211004","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/HYPERTENSIONAHA.111.183996","article-title":"KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism.","volume":"59","author":"Mulatero","year":"2011","journal-title":"Hypertension"},{"key":"R27-4-20211004","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1210\/jc.2003-030490","article-title":"50th anniversary of aldosterone.","volume":"88","author":"Williams","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R28-4-20211004","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jsbmb.2004.04.012","article-title":"Role of voltage-gated calcium channels in potassium-stimulated aldosterone secretion from rat adrenal zona glomerulosa cells.","volume":"92","author":"Uebele","year":"2004","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R29-4-20211004","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.HYP.0000079505.25750.11","article-title":"Primary aldosteronism and hypertensive disease.","volume":"42","author":"Mosso","year":"2003","journal-title":"Hypertension"},{"key":"R30-4-20211004","first-page":"1863","article-title":"Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile and molecular biology.","volume":"85","author":"Fardella","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R31-4-20211004","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1440-1681.1994.tb02519.x","article-title":"High incidence of primary aldosteronism in 199 patients referred with hypertension.","volume":"21","author":"Gordon","year":"1994","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R34-4-20211004","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/355262a0","article-title":"A chimeric 11beta-hydroxylasealdosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension.","volume":"355","author":"Lifton","year":"1992","journal-title":"Nature"},{"key":"R35-4-20211004","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1440-1681.1992.tb00462.x","article-title":"Familial hyperalodsteronism type II: five families with a new variety of primary aldosteronism.","volume":"19","author":"Stowasser","year":"1992","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R36-4-20211004","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1136\/jmg.37.11.831","article-title":"A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22).","volume":"37","author":"Lafferty","year":"2000","journal-title":"J Med Genet"},{"key":"R37-4-20211004","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1210\/jc.2008-0594","article-title":"A novel form of human Mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism.","volume":"93","author":"Geller","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R38-4-20211004","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.1198785","article-title":"K channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.","volume":"331","author":"Choi","year":"2011","journal-title":"Science"},{"key":"R39-4-20211004","doi-asserted-by":"crossref","first-page":"10914","DOI":"10.1073\/pnas.90.23.10914","article-title":"Antioncogenes and human cancer.","volume":"90","author":"Knudson","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R40-4-20211004","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S1262-3636(07)70311-7","article-title":"Diabetes and hypoglycaemia in young children and mutations in the Kir6.2 subunit of the potassium channel: therapeutic consequences.","volume":"32","author":"Flechtner","year":"2006","journal-title":"Diabetes Metab"},{"key":"R41-4-20211004","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1126\/science.1145720","article-title":"The genomic landscapes of human breast and colorectal cancers.","volume":"318","author":"Wood","year":"2007","journal-title":"Science"},{"key":"R42-4-20211004","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1126\/science.1133427","article-title":"The consensus coding sequences of human breast and colorectal cancers.","volume":"314","author":"Sjoblom","year":"2006","journal-title":"Science"},{"key":"R43-4-20211004","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1126\/science.1164382","article-title":"An integrated genomic analysis of human glioblastoma multiforme.","volume":"321","author":"Parsons","year":"2008","journal-title":"Science"},{"key":"R44-4-20211004","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1210\/jc.2008-2333","article-title":"Mutations in regulatory subunit type 1A of cyclic adenosine 5 monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes.","volume":"94","author":"Bertherat","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R45-4-20211004","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00005792-198507000-00007","article-title":"The complex of myxomas, spotty pigmentation, and endocrine overactivity.","volume":"64","author":"Carney","year":"1985","journal-title":"Medicine"},{"key":"R46-4-20211004","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.beem.2010.03.003","article-title":"Clinical and molecular genetics of Carney complex.","volume":"24","author":"Rothenbuhler","year":"2010","journal-title":"Best Prac Res Clin Endocrinol Metab"},{"key":"R47-4-20211004","first-page":"9","article-title":"A PRKAR1A mutation associated with PPNAD in 12 kindreds.","volume":"91","author":"Groussin","year":"1943","journal-title":"J Clin Endocrinol Metab"},{"key":"R48-4-20211004","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1158\/1078-0432.CCR-08-0106","article-title":"Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors.","volume":"14","author":"Libe","year":"2008","journal-title":"Clin Cancer Res"},{"key":"R49-4-20211004","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/ng1809","article-title":"A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia.","volume":"38","author":"Horvath","year":"2006","journal-title":"Nat Genet"},{"key":"R50-4-20211004","doi-asserted-by":"crossref","first-page":"E208","DOI":"10.1210\/jc.2010-1704","article-title":"Frequent phosphodiesterase 11A gene (PDE11A) defects in patients with Carney complex (CNC) caused by PRKAR1A mutations: PDE11A may contribute to adrenal and testicular tumors in CNC as a modifier of the phenotype.","volume":"96","author":"Libe","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R51-4-20211004","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1210\/jc.2006-0188","article-title":"PRKAR1A mutations and protein kinase A interactions with other signaling pathways in the adrenal cortex.","volume":"91","author":"Robinson-White","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R52-4-20211004","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1210\/er.2003-0031","article-title":"11 beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response.","volume":"25","author":"Tomlinson","year":"2004","journal-title":"Endocr Rev"},{"key":"R53-4-20211004","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.mce.2006.12.022","article-title":"Hexose 6-phosphate dehydrogenase (H6PD) and corticosteroid metabolism.","volume":"256-","author":"White","year":"2007","journal-title":"Mol Cell Endocrinol"},{"key":"R54-4-20211004","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1210\/jc.2008-0743","article-title":"Steroid biomarkers and genetic studies reveal inactivating mutations in hexose-6-phosphate dehydrogenase in patients with cortisone reductase deficiency.","volume":"93","author":"Lavery","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R55-4-20211004","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1073\/pnas.1014934108","article-title":"Cortisone-reductase deficiency associated with heterozygous mutations in 11beta-hydroxysteroid dehydrogenase type 1.","volume":"108","author":"Lawson","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"R56-4-20211004","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/jmg.38.1.43","article-title":"Sensitivity and predictive value of criteria for p53 germline mutation screening.","volume":"38","author":"Chompret","year":"2001","journal-title":"J Med Genet"},{"key":"R58-4-20211004","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1530\/eje.1.02004","article-title":"Molecular genetics of adrenocortical tumours, from familial to sporadic diseases.","volume":"153","author":"Libe","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"R59-4-20211004","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1158\/0008-5472.427.65.2","article-title":"Genetic mapping of a third Li-Fraumeni syndrome predisposition locus to human chromosome 1q23.","volume":"65","author":"Bachinski","year":"2005","journal-title":"Cancer Res"},{"key":"R60-4-20211004","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/humu.10081","article-title":"The IARC TP53 database: new online mutation analysis and recommendations to users.","volume":"19","author":"Olivier","year":"2002","journal-title":"Hum Mutat"},{"key":"R62-4-20211004","first-page":"344","article-title":"Segregation analysis of cancer in families of childhood soft tissue sarcoma patients.","volume":"51","author":"Lustbader","year":"1992","journal-title":"Am J Hum Genet"},{"key":"R63-4-20211004","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1470-2045(11)70119-X","article-title":"Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study.","volume":"12","author":"Villani","year":"2011","journal-title":"Lancet Oncol"}],"container-title":["Current Opinion in Endocrinology, Diabetes & Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01266029-201206000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T06:48:25Z","timestamp":1688453305000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01266029-201206000-00004"}},"subtitle":["an update"],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/med.0b013e328352f013","relation":{},"ISSN":["1752-296X"],"issn-type":[{"value":"1752-296X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}